Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Peter Bader
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Procedures
Living Beings
Disorders
Chemicals & Drugs
Concepts & Ideas
Phenomena
Anatomy
Sign-in to see full Profile
Network (preview)
52
Klingebiel, Thomas
48
Niethammer, Dietrich
30
Handgretinger, Rupert
27
Lang, Peter
21
Kreyenberg, Hermann
20
Schlegel, Paul
18
Beck, James
15
Greil, Johann
14
Schumm, Michael
9
Eyrich, Matthias
8
Einsele, Hermann
8
Niemeyer, Charlotte
7
Schwabe, Dirk
7
Dilloo, Dagmar
7
Kremens, Bernhard
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Peter Bader (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Weber G; Karbach J; Kuçi S; Kreyenberg H; Willasch A; Koscielniak E; Tonn T; Klingebiel T; Wels W S; Jäger E; Bader P
WT1 peptide-specific T cells generated from peripheral blood of healthy donors: possible implications for adoptive immunotherapy after allogeneic stem cell transplantation.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2009;23(9):1634-42.
-
2009: Willasch A M; Gruhn B; Coliva T; Kalinova M; Schneider G; Kreyenberg H; Steinbach D; Weber G; Hollink I H I M; Zwaan C M; Biondi A; van der Velden V H J; Reinhardt D; Cazzaniga G; Bader P; Trka J;
Standardization of WT1 mRNA quantitation for minimal residual disease monitoring in childhood AML and implications of WT1 gene mutations: a European multicenter study.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2009;23(8):1472-9.
-
2009: Kuçi Selim; Kuçi Zyrafete; Latifi-Pupovci Hatixhe; Niethammer Dietrich; Handgretinger Rupert; Schumm Michael; Bruchelt Gernot; Bader Peter; Klingebiel Thomas
Adult stem cells as an alternative source of multipotential (pluripotential) cells in regenerative medicine.
Current stem cell research & therapy 2009;4(2):107-17.
-
2009: Bader Peter; Kreyenberg Hermann; Henze Günter H R; Eckert Cornelia; Reising Miriam; Willasch Andre; Barth Andrea; Borkhardt Arndt; Peters Christina; Handgretinger Rupert; Sykora Karl-Walter; Holter Wolfgang; Kabisch Hartmut; Klingebiel Thomas; von Stackelberg Arend;
Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(3):377-84.
-
2008: Klingebiel T; Reinhardt D; Bader P;
Place of HSCT in treatment of childhood AML.
Bone marrow transplantation 2008;42 Suppl 2():S7-9.
-
2008: Schulze Johannes; Bader Peter; Henke Ulrike; Rose Markus A; Zielen Stefan
Severe bullous pemphigoid in an infant--successful treatment with rituximab.
Pediatric dermatology 2008;25(4):462-5.
-
2008: Klingebiel T; Bader P;
Delayed lymphocyte infusion in children given SCT.
Bone marrow transplantation 2008;41 Suppl 2():S23-6.
-
2008: Beck Olaf; Koehl Ulrike; Tramsen Lars; Mousset Sabine; Latgé Jean Paul; Müller Katrin; Schwabe Dirk; Bader Peter; Klingebiel Thomas; Lehrnbecher Thomas
Enumeration of functionally active anti-Aspergillus T-cells in human peripheral blood.
Journal of immunological methods 2008;335(1-2):41-5.
-
2008: Kuçi S; Kuçi Z; Schmid S; Seitz G; Müller I; Dufke A; Leimig T; Murti G; Jurecic R; Schumm M; Lang P; Bruchelt G; Bader P; Klingebiel T; Niethammer D; Handgretinger R
Efficient in vitro generation of adult multipotent cells from mobilized peripheral blood CD133+ cells.
Cell proliferation 2008;41(1):12-27.
-
2008: Archambeault Sophie; Flores Nikki J; Yoshimi Ayami; Kratz Christian P; Reising Miriam; Fischer Alexandra; Noellke Peter; Locatelli Franco; Sedlacek Petr; Flotho Christian; Zecca Marco; Emanuel Peter D; Castleberry Robert P; Niemeyer Charlotte M; Bader Peter; Loh Mignon L
Development of an allele-specific minimal residual disease assay for patients with juvenile myelomonocytic leukemia.
Blood 2008;111(3):1124-7.
-
2008: Koehl U; Bochennek K; Esser R; Brinkmann A; Quaritsch R; Becker M; Soerensen J; Bader P; Schwabe D; Klingebiel T; Fischer J; Zimmermann S Y
ISHAGE-based single-platform flowcytometric analysis for measurement of absolute viable T cells in fresh or cryopreserved products: CD34/CD133 selected or CD3/CD19 depleted stem cells, DLI and purified CD56+CD3- NK cells.
International journal of hematology 2008;87(1):98-105.
-
2008: Lang Peter; Mueller Ingo; Greil Johann; Bader Peter; Schumm Michael; Pfeiffer Matthias; Hoelle Walter; Klingebiel Thomas; Heinzelmann Frank; Belka Claus; Schlegel Paul G; Kremens Bernhard; Woessmann Wilhelm; Handgretinger Rupert
Retransplantation with stem cells from mismatched related donors after graft rejection in pediatric patients.
Blood cells, molecules & diseases 2008;40(1):33-9.
-
2007: Strahm B; Locatelli F; Bader P; Ehlert K; Kremens B; Zintl F; Führer M; Stachel D; Sykora K-W; Sedlacek P; Baumann I; Niemeyer C M
Reduced intensity conditioning in unrelated donor transplantation for refractory cytopenia in childhood.
Bone marrow transplantation 2007;40(4):329-33.
-
2007: van der Velden V H J; Cazzaniga G; Schrauder A; Hancock J; Bader P; Panzer-Grumayer E R; Flohr T; Sutton R; Cave H; Madsen H O; Cayuela J M; Trka J; Eckert C; Foroni L; Zur Stadt U; Beldjord K; Raff T; van der Schoot C E; van Dongen J J M;
Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(4):604-11.
-
2007: Hartwig M; Weigel S; Bernig T; Bader P; Dölken R; Beck J
Maintenance immunotherapy by repetitive low-dose donor lymphocytes infusions in a child with relapse state aml after allogeneic stem cell transplantation.
Pediatric hematology and oncology 2007;24(2):137-40.
-
2007: Koehl U; Bochennek K; Zimmermann S Y; Lehrnbecher T; Sörensen J; Esser R; Andreas C; Kramm C; Grüttner H P; Falkenberg E; Orth A; Bader P; Schwabe D; Klingebiel T
Immune recovery in children undergoing allogeneic stem cell transplantation: absolute CD8+ CD3+ count reconstitution is associated with survival.
Bone marrow transplantation 2007;39(5):269-78.
-
2007: Willasch Andre; Schneider Gaby; Reincke Britta Sofia; Shayegi Nona; Kreyenberg Hermann; Kuci Selim; Weber Gerrit; Van Der Reijden Bert; Niethammer Dietrich; Klingebiel Thomas; Bader Peter
Sequence polymorphism systems for quantitative real-time polymerase chain reaction to characterize hematopoietic chimerism-high informativity and sensitivity as well as excellent reproducibility and precision of measurement.
Laboratory hematology : official publication of the International Society for Laboratory Hematology 2007;13(3):73-84.
-
2006: Klingebiel T; Bader P; Hollatz G; Koehl U; Lehrnbecher T; Meisel R; Dilloo D
Immunotherapy in children: report from the Reisensburg-Symposium October 20-22, 2004 and recent advances.
Klinische Pädiatrie 2006;218(6):355-65.
-
2006: Willasch Andre; Hoelle Walter; Kreyenberg Hermann; Niethammer Dietrich; Handgretinger Rupert; Lang Peter; Beck James F; Klingebiel Thomas; Bader Peter
Outcome of allogeneic stem cell transplantation in children with non-malignant diseases.
Haematologica 2006;91(6):788-94.
-
2006: Lehrnbecher Thomas; Becker Martina; Schwabe Dirk; Köhl Ulrike; Kriener Susanne; Hunfeld Klaus-Peter; Schmidt Helga; Beyer Peter; Klingebiel Thomas; Bader Peter; Sörensen Jan
Primary intestinal aspergillosis after high-dose chemotherapy and autologous stem cell rescue.
The Pediatric infectious disease journal 2006;25(5):465-6.
-
2006: Sonnemann Jürgen; Kumar K Saravana; Heesch Sandra; Müller Cornelia; Hartwig Christoph; Maass Manfred; Bader Peter; Beck James F
Histone deacetylase inhibitors induce cell death and enhance the susceptibility to ionizing radiation, etoposide, and TRAIL in medulloblastoma cells.
International journal of oncology 2006;28(3):755-66.
-
2006: Beck O; Seidl C; Lehrnbecher T; Kreyenberg H; Schwabe D; Klingebiel T; Seifried E; Bader P; Koehl U
Quantification of chimerism within peripheral blood, bone marrow and purified leukocyte subsets: comparison of singleplex and multiplex PCR amplification of short tandem repeat (STR) loci.
European journal of haematology 2006;76(3):237-44.
-
2005: Koehl U; Esser R; Zimmermann S; Tonn T; Kotchetkov R; Bartling T; Sörensen J; Grüttner H-P; Bader P; Seifried E; Martin H; Lang P; Passweg J R; Klingebiel T; Schwabe D
Ex vivo expansion of highly purified NK cells for immunotherapy after haploidentical stem cell transplantation in children.
Klinische Pädiatrie 2005;217(6):345-50.
-
2005: Feuchtinger T; Richard C; Pfeiffer M; Neuhäuser F; Lücke J; Handgretinger R; Greil J; Bader P; Klingebiel T; Schlegel P-G; Jahn G; Niethammer D; Lang P
Adenoviral infections after transplantation of positive selected stem cells from haploidentical donors in children: an update.
Klinische Pädiatrie 2005;217(6):339-44.
-
2005: Lang P; Schumm M; Greil J; Bader P; Klingebiel T; Müller I; Feuchtinger T; Pfeiffer M; Schlegel P-G; Niethammer D; Handgretinger R
A comparison between three graft manipulation methods for haploidentical stem cell transplantation in pediatric patients: preliminary results of a pilot study.
Klinische Pädiatrie 2005;217(6):334-8.
-
2005: Kontny Udo; Boppana Sridhar; Jung Andreas; Goebel Heike; Strahm Brigitte; Peters Anke; Dormann Sabine; Werner Martin; Bader Peter; Fisch Paul; Niemeyer Charlotte
Post-transplantation lymphoproliferative disorder of recipient origin in a boy with acute T-cell leukemia with detection of B-cell clonality 3 months before stem cell transplantation.
Haematologica 2005;90 Suppl():ECR27.
-
2005: Yoshimi A; Bader P; Matthes-Martin S; Starý J; Sedlacek P; Duffner U; Klingebiel T; Dilloo D; Holter W; Zintl F; Kremens B; Sykora K-W; Urban C; Hasle H; Korthof E; Révész T; Fischer A; Nöllke P; Locatelli F; Niemeyer C M;
Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(6):971-7.
-
2005: Yoshimi Ayami; Niemeyer Charlotte M; Bohmer Viktoria; Duffner Ulrich; Strahm Brigitte; Kreyenberg Hermann; Dilloo Dagmar; Zintl Felix; Claviez Alexander; Wössmann Willi; Kremens Bernhard; Holter Wolfgang; Niethammer Dietrich; Beck James F; Kontny Udo; Nöllke Peter; Klingebiel Thomas; Bader Peter
Chimaerism analyses and subsequent immunological intervention after stem cell transplantation in patients with juvenile myelomonocytic leukaemia.
British journal of haematology 2005;129(4):542-9.
-
2005: Klingebiel Thomas; Lang Peter; Schumm Michael; Koehl Ulrike; Bader Peter; Schwabe Dirk; Schlegel Paul G; Eyrich Matthias; Greil Johann; Beck James F; Niethammer Dietrich; Handgretinger Rupert
Experiences with haploidentical stem cell transplantation in children with acute lymphoblastic leukemia.
Pathologie-biologie 2005;53(3):159-61.
-
2005: Kerst Gunter; Kreyenberg Hermann; Roth Carmen; Well Catrin; Dietz Klaus; Coustan-Smith Elaine; Campana Dario; Koscielniak Ewa; Niemeyer Charlotte; Schlegel Paul G; Müller Ingo; Niethammer Dietrich; Bader Peter
Concurrent detection of minimal residual disease (MRD) in childhood acute lymphoblastic leukaemia by flow cytometry and real-time PCR.
British journal of haematology 2005;128(6):774-82.
-
2005: Sonnemann Jürgen; Gänge Jennifer; Kumar K Saravana; Müller Cornelia; Bader Peter; Beck James F
Histone deacetylase inhibitors interact synergistically with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to induce apoptosis in carcinoma cell lines.
Investigational new drugs 2005;23(2):99-109.
-
2005: Eyrich Matthias; Wollny Gernot; Tzaribaschev Nikolaj; Dietz Klaus; Brügger Dorothee; Bader Peter; Lang Peter; Schilbach Karin; Winkler Beate; Niethammer Dietrich; Schlegel Paul G
Onset of thymic recovery and plateau of thymic output are differentially regulated after stem cell transplantation in children.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(3):194-205.
-
2005: Bader Peter; Niemeyer Charlotte; Willasch Andre; Kreyenberg Hermann; Strahm Brigitte; Kremens Bernhard; Gruhn Bernd; Dilloo Dagmar; Vormoor Josef; Lang Peter; Niethammer Dietrich; Klingebiel Thomas; Beck James F
Children with myelodysplastic syndrome (MDS) and increasing mixed chimaerism after allogeneic stem cell transplantation have a poor outcome which can be improved by pre-emptive immunotherapy.
British journal of haematology 2005;128(5):649-58.
-
2005: Bader P; Niethammer D; Willasch A; Kreyenberg H; Klingebiel T
How and when should we monitor chimerism after allogeneic stem cell transplantation?
Bone marrow transplantation 2005;35(2):107-19.
-
2005: Locatelli Franco; Nöllke Peter; Zecca Marco; Korthof Elisabeth; Lanino Edoardo; Peters Christina; Pession Andrea; Kabisch Hartmut; Uderzo Cornelio; Bonfim Carmen S; Bader Peter; Dilloo Dagmar; Stary Jan; Fischer Alexandra; Révész Tom; Führer Monika; Hasle Henrik; Trebo Monika; van den Heuvel-Eibrink Marry M; Fenu Susanna; Strahm Brigitte; Giorgiani Giovanna; Bonora Mario Regazzi; Duffner Ulrich; Niemeyer Charlotte M;
Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial.
Blood 2005;105(1):410-9.
-
2004: Lang Peter; Greil Johann; Bader Peter; Handgretinger Rupert; Klingebiel Thomas; Schumm Michael; Schlegel Paul-Gerhard; Feuchtinger Tobias; Pfeiffer Matthias; Scheel-Walter Hans; Führer Monika; Martin David; Niethammer Dietrich
Long-term outcome after haploidentical stem cell transplantation in children.
Blood cells, molecules & diseases 2004;33(3):281-7.
-
2004: Klingebiel Thomas; Handgretinger Rupert; Lang Peter; Bader Peter; Niethammer Dietrich
Haploidentical transplantation for acute lymphoblastic leukemia in childhood.
Blood reviews 2004;18(3):181-92.
-
2004: Bader Peter; Niemeyer Charlotte; Weber Gerrit; Coliva Tiziana; Rossi Vincenzo; Kreyenberg Hermann; Gerecke Anja; Biondi Andrea
WT1 gene expression: useful marker for minimal residual disease in childhood myelodysplastic syndromes and juvenile myelo-monocytic leukemia?
European journal of haematology 2004;73(1):25-8.
-
2004: Sonnemann Jürgen; Gekeler Volker; Ahlbrecht Katrin; Brischwein Klaus; Liu Chao; Bader Peter; Müller Cornelia; Niethammer Dietrich; Beck James F
Down-regulation of protein kinase Ceta by antisense oligonucleotides sensitises A549 lung cancer cells to vincristine and paclitaxel.
Cancer letters 2004;209(2):177-85.
-
2004: Bader Peter; Kreyenberg Hermann; Hoelle Walter; Dueckers Gregor; Handgretinger Rupert; Lang Peter; Kremens Bernhard; Dilloo Dagmar; Sykora Karl-Walter; Schrappe Martin; Niemeyer Charlotte; Von Stackelberg Arend; Gruhn Bernd; Henze Günter; Greil Johann; Niethammer Dietrich; Dietz Klaus; Beck James F; Klingebiel Thomas
Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(9):1696-705.
-
2004: Bader P; Kreyenberg H; Hoelle W; Dueckers G; Kremens B; Dilloo D; Sykora K-W; Niemeyer C; Reinhardt D; Vormoor J; Gruhn B; Lang P; Greil J; Handgretinger R; Niethammer D; Klingebiel T; Beck J F
Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective.
Bone marrow transplantation 2004;33(8):815-21.
-
2004: Lang P; Klingebiel T; Bader P; Greil J; Schumm M; Schlegel P-G; Eyrich M; Mueller-Weihrich S; Niethammer D; Handgretinger R
Transplantation of highly purified peripheral-blood CD34+ progenitor cells from related and unrelated donors in children with nonmalignant diseases.
Bone marrow transplantation 2004;33(1):25-32.
-
2004: Lang Peter; Bader Peter; Schumm Michael; Feuchtinger Tobias; Einsele Hermann; Führer Monika; Weinstock Christof; Handgretinger Rupert; Kuci Selim; Martin David; Niethammer Dietrich; Greil Johann
Transplantation of a combination of CD133+ and CD34+ selected progenitor cells from alternative donors.
British journal of haematology 2004;124(1):72-9.
-
2004: Hoelle W; Beck J F; Dueckers G; Kreyenberg H; Lang P; Gruhn B; Führer M; Niethammer D; Klingebiel T; Bader P
Clinical relevance of serial quantitative analysis of hematopoietic chimerism after allogeneic stem cell transplantation in children for severe aplastic anemia.
Bone marrow transplantation 2004;33(2):219-23.
-
2004: Bader Peter; Kreyenberg Hermann
Analysis of chimerism after stem cell transplantation.
Methods in molecular medicine 2004;91():247-64.
-
2003: Krejci O; van der Velden V H J; Bader P; Kreyenberg H; Goulden N; Hancock J; Schilham M W; Lankester A; Révész T; Klingebiel T; van Dongen J J M
Level of minimal residual disease prior to haematopoietic stem cell transplantation predicts prognosis in paediatric patients with acute lymphoblastic leukaemia: a report of the Pre-BMT MRD Study Group.
Bone marrow transplantation 2003;32(8):849-51.
-
2003: Wiesmann A; Bader P; Faul C; Schnaidt M; Kanz L; Einsele H
Successful haematopoietic stem cell transplantation from a matched unrelated donor following three graft failures from HLA-mismatched related donors.
Bone marrow transplantation 2003;32(7):729-31.
-
2003: Koch M; Lang P; Bader P; Kreyenberg H; Schumm M; Scheel-Walter H; Hochhaus A; Niethammer D; Greil J
Successful unrelated allogeneic stem cell transplantation after treatment of lymphoid blast crisis CML with imatinib and imatinib-containing conditioning regimen in a 16-year-old male.
Bone marrow transplantation 2003;32(5):541-2.
-
2003: Wiesmann A; Bader P; Bamberg M; Faul C; Kanz L; Einsele H
Severe acute graft-versus-host disease after T-cell depleted allogeneic stem cell graft from a second donor caused by persisting T-cells from the first donor.
Bone marrow transplantation 2003;32(5):511-3.
-
2003: Eyrich M; Leiler C; Lang P; Schilbach K; Schumm M; Bader P; Greil J; Klingebiel T; Handgretinger R; Niethammer D; Schlegel P G
A prospective comparison of immune reconstitution in pediatric recipients of positively selected CD34+ peripheral blood stem cells from unrelated donors vs recipients of unmanipulated bone marrow from related donors.
Bone marrow transplantation 2003;32(4):379-90.
-
2003: Goulden Nick; Bader Peter; Van Der Velden Vincent; Moppett John; Schilham Marco; Masden Hans O; Krejci Ondrej; Kreyenberg Hermann; Lankester Arjan; Révész Tom; Klingebiel Thomas; Van Dongen Jacques
Minimal residual disease prior to stem cell transplant for childhood acute lymphoblastic leukaemia.
British journal of haematology 2003;122(1):24-9.
-
2003: Tomaske Maren; Bosk Axel; Eyrich Matthias; Bader Peter; Niethammer Dietrich
Risks of mortality in children admitted to the paediatric intensive care unit after haematopoietic stem cell transplantation.
British journal of haematology 2003;121(6):886-91.
-
2003: Einsele Hermann; Schäfer Hans-Jörg; Hebart Holger; Bader Peter; Meisner Christoph; Plasswilm Ludwig; Liebisch Peter; Bamberg Michael; Faul Christoph; Kanz Lothar
Follow-up of patients with progressive multiple myeloma undergoing allografts after reduced-intensity conditioning.
British journal of haematology 2003;121(3):411-8.
-
2003: Kuçi Selim; Wessels Johannes T; Bühring Hans-Jörg; Schilbach Karin; Schumm Michael; Seitz Gabriele; Löffler Jürgen; Bader Peter; Schlegel Paul G; Niethammer Dietrich; Handgretinger Rupert
Identification of a novel class of human adherent CD34- stem cells that give rise to SCID-repopulating cells.
Blood 2003;101(3):869-76.
-
2003: Lang Peter; Handgretinger Rupert; Niethammer Dietrich; Schlegel Paul G; Schumm Michael; Greil Johann; Bader Peter; Engel Corinna; Scheel-Walter Hans; Eyrich Matthias; Klingebiel Thomas
Transplantation of highly purified CD34+ progenitor cells from unrelated donors in pediatric leukemia.
Blood 2003;101(4):1630-6.
-
2002: Loeffler Juergen; Bauer Ralf; Hebart Holger; Douek Daniel C; Rauser Georg; Bader Peter; Einsele Hermann
Quantification of T-cell receptor excision circle DNA using fluorescence resonance energy transfer and the LightCycler system.
Journal of immunological methods 2002;271(1-2):167-75.
-
2002: Brügger Dorothee; Brischwein Klaus; Liu Chao; Bader Peter; Niethammer Dietrich; Gekeler Volker; Beck James F
Induction of drug resistance and protein kinase C genes in A2780 ovarian cancer cells after incubation with antineoplastic agents at sublethal concentrations.
Anticancer research 2002;22(6C):4229-32.
-
2002: Bader P; Hancock J; Kreyenberg H; Goulden N J; Niethammer D; Oakhill A; Steward C G; Handgretinger R; Beck J F; Klingebiel T
Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(9):1668-72.
-
2002: Eyrich Matthias; Croner Tanja; Leiler Christine; Lang Peter; Bader Peter; Klingebiel Thomas; Niethammer Dietrich; Schlegel Paul G
Distinct contributions of CD4(+) and CD8(+) naive and memory T-cell subsets to overall T-cell-receptor repertoire complexity following transplantation of T-cell-depleted CD34-selected hematopoietic progenitor cells from unrelated donors.
Blood 2002;100(5):1915-8.
-
2002: Beck J F; Klingebiel T; Kreyenberg H; Schaudt A; Wölle W; Niethammer D; Bader P
[Relapse of childhood ALL, AML and MDS after allogeneic stem cell transplantation can be prevented by donor lymphocyte infusion in a critical stage of increasing mixed chimerism]
Klinische Pädiatrie 2002;214(4):201-5.
-
2002: Seitz G; Kohler G; Nehmzow M; Lorenz G; Denzlinger C; Müller C; Bader P; Brischwein K; Beck J F
Potentially therapeutically relevant differences of antisense oligonucleotide uptake in CD34+ hematopoietic stem cells, leukemic blasts and cancer cells from patients.
Anticancer research 2002;22(3):1717-9.
-
2002: Bader P; Dückers G; Kreyenberg H; Hoelle W; Kerst G; Lang P; Greil J; Niethammer D; Beck L F; Klingebiel T
Monitoring of donor cell chimerism for the detection of relapse and early immunotherapeutic intervention in acute lymphoblastic leukemias.
Annals of hematology 2002;81 Suppl 2():S25-7.
-
2001: Stilz R; Grünebach F; Bader P; Vogel W; Kanz L; Brugger W; Scheding S
Ex vivo expansion of normal progenitor cells from acute myeloid leukemia cell-contaminated CD34+ peripheral blood progenitor cells after mafosfamide purging.
Journal of hematotherapy & stem cell research 2001;10(6):777-85.
-
2001: Eyrich M; Lang P; Lal S; Bader P; Handgretinger R; Klingebiel T; Niethammer D; Schlegel P G
A prospective analysis of the pattern of immune reconstitution in a paediatric cohort following transplantation of positively selected human leucocyte antigen-disparate haematopoietic stem cells from parental donors.
British journal of haematology 2001;114(2):422-32.
-
2001: Beck J F; Brügger D; Brischwein K; Liu C; Bader P; Niethammer D; Gekeler V
Anticancer drug-mediated induction of multidrug resistance-associated genes and protein kinase C isozymes in the T-lymphoblastoid cell line CCRF-CEM and in blasts from patients with acute lymphoblastic leukemias.
Japanese journal of cancer research : Gann 2001;92(8):896-903.
-
2001: Handgretinger R; Lang P; Schumm M; Pfeiffer M; Gottschling S; Demirdelen B; Bader P; Kuci S; Klingebiel T; Niethammer D
Immunological aspects of haploidentical stem cell transplantation in children.
Annals of the New York Academy of Sciences 2001;938():340-57; discussion 357-8.
-
2001: Handgretinger R; Klingebiel T; Lang P; Schumm M; Neu S; Geiselhart A; Bader P; Schlegel P G; Greil J; Stachel D; Herzog R J; Niethammer D
Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children.
Bone marrow transplantation 2001;27(8):777-83.
-
2000: Schlegel P G; Eyrich M; Bader P; Handgretinger R; Lang P; Niethammer D; Klingebiel T
OKT-3-based reconditioning regimen for early graft failure in HLA-non-identical stem cell transplants.
British journal of haematology 2000;111(2):668-73.
-
2000: Hebart H; Löffler J; Reitze H; Engel A; Schumacher U; Klingebiel T; Bader P; Böhme A; Martin H; Bunjes D; Kern W V; Kanz L; Einsele H
Prospective screening by a panfungal polymerase chain reaction assay in patients at risk for fungal infections: implications for the management of febrile neutropenia.
British journal of haematology 2000;111(2):635-40.
-
2000: Einsele H; Hebart H; Kauffmann-Schneider C; Sinzger C; Jahn G; Bader P; Klingebiel T; Dietz K; Löffler J; Bokemeyer C; Müller C A; Kanz L
Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection.
Bone marrow transplantation 2000;25(7):757-63.
-
2000: Bader P; Stoll K; Huber S; Geiselhart A; Handgretinger R; Niemeyer C; Einsele H; Schlegel P G; Niethammer D; Beck J; Klingebiel T
Characterization of lineage-specific chimaerism in patients with acute leukaemia and myelodysplastic syndrome after allogeneic stem cell transplantation before and after relapse.
British journal of haematology 2000;108(4):761-8.
-
1999: Bader P; Klingebiel T; Schaudt A; Theurer-Mainka U; Handgretinger R; Lang P; Niethammer D; Beck J F
Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed chimerism: a single center experience of 12 children.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1999;13(12):2079-86.
-
1999: Eckstein F S; Heinemann M K; Mielke G J; Greschniok A; Bader P; Ziemer G
Resection of a large right atrial hemangioma in a neonate after prenatal diagnosis.
The Annals of thoracic surgery 1999;68(3):1074-5.
-
1999: Bosk A; Bader P; Mielke G; Heinemann M K; Sieverding L
[Extensive cavernous capillary hemangioma of the right atrium in a newborn infant]
Zeitschrift für Geburtshilfe und Neonatologie 1999;203(3):120-2.
-
1999: Brügger D; Herbart H; Gekeler V; Seitz G; Liu C; Klingebiel T; Orlikowsky T; Einsele H; Denzlinger C; Bader P; Niethammer D; Beck J F
Functional analysis of P-glycoprotein and multidrug resistance associated protein related multidrug resistance in AML-blasts.
Leukemia research 1999;23(5):467-75.
-
1999: Handgretinger R; Schumm M; Lang P; Greil J; Reiter A; Bader P; Niethammer D; Klingebiel T
Transplantation of megadoses of purified haploidentical stem cells.
Annals of the New York Academy of Sciences 1999;872():351-61; discussion 361-2.
-
1998: Klingebiel T; Bader P; Bares R; Beck J; Hero B; Jürgens H; Lang P; Niethammer D; Rath B; Handgretinger R
Treatment of neuroblastoma stage 4 with 131I-meta-iodo-benzylguanidine, high-dose chemotherapy and immunotherapy. A pilot study.
European journal of cancer (Oxford, England : 1990) 1998;34(9):1398-402.
-
1998: Hebart H; Gamer D; Loeffler J; Mueller C; Sinzger C; Jahn G; Bader P; Klingebiel T; Kanz L; Einsele H
Evaluation of Murex CMV DNA hybrid capture assay for detection and quantitation of cytomegalovirus infection in patients following allogeneic stem cell transplantation.
Journal of clinical microbiology 1998;36(5):1333-7.
-
1998: Beck J F; Bohnet B; Brügger D; Dietl J; Scheper R J; Bader P; Niethammer D; Gekeler V
Expression analysis of protein kinase C isozymes and multidrug resistance associated genes in ovarian cancer cells.
Anticancer research 1998;18(2A):701-5.
-
1998: Bader P; Beck J; Frey A; Schlegel P G; Hebarth H; Handgretinger R; Einsele H; Niemeyer C; Benda N; Faul C; Kanz L; Niethammer D; Klingebiel T
Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT.
Bone marrow transplantation 1998;21(5):487-95.
-
1998: Schlegel P G; Haber H P; Beck J; Krümpelmann S; Handgretinger R; Bader P; Bierings M; Niethammer D; Klingebiel T
Hepatic veno-occlusive disease in pediatric stem cell recipients: successful treatment with continuous infusion of prostaglandin E1 and low-dose heparin.
Annals of hematology 1998;76(1):37-41.
-
1998: Beck J; Bohnet B; Brügger D; Bader P; Dietl J; Scheper R J; Kandolf R; Liu C; Niethammer D; Gekeler V
Multiple gene expression analysis reveals distinct differences between G2 and G3 stage breast cancers, and correlations of PKC eta with MDR1, MRP and LRP gene expression.
British journal of cancer 1998;77(1):87-91.
-
1997: Bader P; Beck J; Schlegel P G; Handgretinger R; Niethammer D; Klingebiel T
Additional immunotherapy on the basis of increasing mixed hematopoietic chimerism after allogeneic BMT in children with acute leukemia: is there an option to prevent relapse?
Bone marrow transplantation 1997;20(1):79-81.
-
1997: Bader P; Hölle W; Klingebiel T; Handgretinger R; Benda N; Schlegel P G; Niethammer D; Beck J
Mixed hematopoietic chimerism after allogeneic bone marrow transplantation: the impact of quantitative PCR analysis for prediction of relapse and graft rejection in children.
Bone marrow transplantation 1997;19(7):697-702.
-
1996: Bader P; Hölle W; Klingebiel T; Handgretinger R; Niethammer D; Beck J
Quantitative assessment of mixed hematopoietic chimerism by polymerase chain reaction after allogeneic BMT.
Anticancer research 1996;16(4A):1759-63.
-
1995: Klingebiel T; Handgretinger R; Herter M; Eppinger T; Bader P; Lang P; Dopfer R; Scheel-Walter H; Haus U; Niethammer D
Autologous transplantation with peripheral blood stem cells in children and young adults after myeloablative treatment: nonrandomized comparison between GM-CSF and G-CSF for mobilization.
Journal of hematotherapy 1995;4(4):307-14.
Sign-in to see more